Harold Davidson & Associates Inc. Abb Vie Inc. Transaction History
Harold Davidson & Associates Inc.
- $154 Billion
- Q2 2025
A detailed history of Harold Davidson & Associates Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Harold Davidson & Associates Inc. holds 9,564 shares of ABBV stock, worth $2.09 Million. This represents 1.15% of its overall portfolio holdings.
Number of Shares
9,564
Previous 9,736
1.77%
Holding current value
$2.09 Million
Previous $2.04 Billion
12.97%
% of portfolio
1.15%
Previous 1.11%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
4,382Shares Held
1.3BCall Options Held
16.1MPut Options Held
10.9M-
Vanguard Group Inc Valley Forge, PA177MShares$38.7 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$29.7 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$17.4 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$11.9 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.09 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $386B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...